MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,000 | -61.3% | 150,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $494,000 | -19.9% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $617,000 | -29.8% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $879,000 | -15.8% | 150,000 | -2.5% | 0.00% | 0.0% |
| Q3 2022 | $1,044,000 | +46.4% | 153,793 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $713,000 | +15.6% | 154,418 | 0.0% | 0.00% | – |
| Q1 2022 | $617,000 | -35.7% | 154,418 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $960,000 | -35.1% | 154,418 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $1,479,000 | -28.1% | 156,764 | +3.5% | 0.00% | -50.0% |
| Q2 2021 | $2,057,000 | -16.1% | 151,498 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $2,451,000 | -39.4% | 151,498 | -0.3% | 0.00% | -50.0% |
| Q4 2020 | $4,044,000 | +42.9% | 151,957 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $2,829,000 | -20.4% | 151,957 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $3,556,000 | – | 151,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $4,564,000 | 3.47% |
| NEA Management Company, LLC | 11,963,649 | $68,552,000 | 3.24% |
| Sarissa Capital Management LP | 3,750,000 | $21,487,000 | 1.78% |
| VHCP Management III, LLC | 1,561,389 | $8,947,000 | 1.78% |
| VHCP Management II, LLC | 922,514 | $5,286,000 | 1.39% |
| Ghost Tree Capital, LLC | 800,000 | $4,584,000 | 0.87% |
| BVF INC/IL | 1,180,553 | $6,765,000 | 0.51% |
| Sio Capital Management, LLC | 166,250 | $953,000 | 0.23% |
| Rock Springs Capital Management LP | 1,233,000 | $7,065,000 | 0.22% |
| DAFNA Capital Management LLC | 108,463 | $621,000 | 0.21% |